Table 1.
Evaluation Scheme of the Clinical Trial
| −1 Week (baseline) | 0 Week (single dose) | 12 Weeks | |
|---|---|---|---|
| Ingestion on test day | • | ||
| Medical interview | • | • | • |
| Height | • | ||
| Weight | • | • | • |
| Vital signs | • | • | • |
| Blood samplinga | • | • | |
| MMSE-J | • | • | |
| Cognitrax test | • | • | • |
On the day of the test, evaluations marked with circles were implemented. Tests were carried out in the order listed in the table.
Blood sampling was performed for hematologic tests (white blood cell count, red blood cell count, hemoglobin concentration, hematocrit, platelet count, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration) and evaluation of biochemical blood parameters (total protein, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase, lactate dehydrogenase, uric acid, urea nitrogen, total bilirubin, albumin, creatinine, fasting blood glucose, and glycated hemoglobin).
MMSE-J, Mini Mental State Examination-Japanese version.